The International Mesothelioma Interest Group (IMIG) is accepting registrations for its annual conference. The 11th International Conference of the Mesothelioma Interest Group (iMig 2012) is taking place from September 11 – 14, 2012, at the Boston Seaport Hotel & World Trade Center. The organizers of the conference aim "to educate, create awareness, prevent and cure mesothelioma."
The conference offers an opportunity for attendees to hear from some of the country's leading mesothelioma experts regarding the future of mesothelioma treatments. More than 500 delegates from around the world are expected to attend the conference that is hosting mesothelioma experts and researchers. According to the press release, the conference will feature workshops, debates, poster and oral abstract sessions and breakout symposia including topics such as immunology, immunotherapy, imaging, pathology as well as surgical pitfalls and challenges.
Co-chairs of the conference are Drs. Raphael Bueno and David Sugarbaker from the Brigham & Women's Hospital, Harvard Medical School. Keynote speakers include Dr. Raja M. Flores, Chief of the Division of Thoracic Surgery at The Mount Sinai Medical Center, Michele Carbone, MD, PhD, Director of the University of Hawaii Cancer Center, and Dr. Joseph Friedberg, co-director of the Penn Mesothelioma and Pleural Program.
Mesothelioma is a serious and incurable cancer that is diagnosed in nearly 3,000 Americans each year. Mesothelioma is almost always a direct consequence of exposure to asbestos fibers. According to the IMIG, in North America, the number of mesothelioma cases has risen steadily over the past two decades, and more than 28 million people have had significant exposure to asbestos. Mesothelioma has a latency period as long as 50 years before the disease develops.
IMIG is an independent international group of scientists and clinicians working to understand, cure and prevent mesothelioma.
See IMIG's website for more information and to register for the conference.
